

Measles: The Cancer Killer?... from Incubation
Dec 19, 2024
Stephen Russell, a former Mayo Clinic researcher and CEO of Vyriad, reveals groundbreaking insights into the measles virus and its unexpected potential as a cancer treatment. Russell discusses how measles can induce immune responses that may aid in tumor remission. He also explores the concept of 'immune amnesia' caused by measles, shedding light on its complex interaction with other infections. The conversation highlights innovative approaches to using viruses as a therapeutic tool, offering hope for future cancer treatments.
AI Snips
Chapters
Transcript
Episode notes
Measles's Hidden Impact
- Measles has more severe consequences than just fever and rash.
- It causes "immune amnesia," weakening the immune system's memory of past infections.
Immune Amnesia
- Immune memory, like other memories, is stored in cells.
- Measles attacks this memory, increasing vulnerability to past infections.
Netherlands Study
- Researchers studied an unvaccinated community in the Netherlands.
- They collected blood samples before and after a measles outbreak to study its effects.